Impella is the only U.S. FDA-approved percutaneous heart pump technology indicated for patients with severe coronary artery disease requiring high-risk PCI

The Impella CP device (Abiomed, Danvers, Massachusetts) is being increasingly used in patients presenting with (acute) cardiogenic shock but also electively in patients undergoing high-risk …

The use of an Impella CP in a PCI is called a Protected PCI (PPCI) procedure, which is performed by an Interventional Cardiologist. A PPCI procedure can reduce complications and risks such …

Learn more about how to identify patients for Protected PCI, including those with complex coronary artery disease, hemodynamic compromise and comorbidities. Read extensive data, …

The PROTECT II economic study concluded that for patients with severe LV dysfunction and complex anatomy, Impella-assisted PCI significantly reduced major adverse events at an …

High-risk PCI with Impella CP periprocedural support was safe and effective in patients with low EF (≤30%). The all-cause mortality rate (6.1% and 13.9%, respectively, for in-hospital and at …

Protected PCI with an Impella CP® with SmartAssist® is a widely accepted procedure used to temporarily assist the pumping function of the heart. Protected stenting with Impella CP …

The Impella heart pump can potentially lower certain risks in patients with severe coronary artery disease who otherwise have stable heart function and are undergoing percutaneous coronary …

device-related mechanical complications. The paper reports that the most common indication for Impella placement was in the set-ting of performance of a high-risk per. utaneous coronary …

PCI is recommended for people with blocked coronary arteries who otherwise have a healthy heart. Protected PCI, or protected stenting, is a widely accepted procedure using Impella®, …